LUO Jianghui, MAO Yuanzhou, ZHANG Kexian, et al. Inhibition of Propofol on Migration and Invasion of Cervical Cancer Cells Through miR-802/PTCH1/SHH Pathway. [J]. 22(10):1164-1171(2022)
DOI:
LUO Jianghui, MAO Yuanzhou, ZHANG Kexian, et al. Inhibition of Propofol on Migration and Invasion of Cervical Cancer Cells Through miR-802/PTCH1/SHH Pathway. [J]. 22(10):1164-1171(2022) DOI: 10.14009/j.issn.1672-2124.2022.10.003.
Inhibition of Propofol on Migration and Invasion of Cervical Cancer Cells Through miR-802/PTCH1/SHH Pathway
OBJECTIVE: To probe into the effects of propofol on migration and invasion of cervical cancer cells through miR-802/PTCH1/SHH pathway. METHODS: Human cervical cancer cells HeLa cells were treated with different concentrations of propofol as the propofol group and dimethyl sulfoxide as the control group. MTT and Transwell were used to detect HeLa cell viability
invasion and migration ability. Real-time fluorescent quantitative polymerase chain reaction(RT-qPCR) was used to detect the expression level of miR-802 and PTCH1 mRNA. The target relationship between miR-802 and PTCH1 was verified by bioinformatics analysis and dual luciferase reporter gene system. NC mimic and miR-802 mimic were transfected into HeLa cells and named as NC mimic group and miR-802 mimic group. NC inhibitor
miR-802 inhibitor
Vector
and pcDNA-PTCH1 were transfected into HeLa cells treated with 10 μg/mL propofol and respectively named as propofol+NC inhibitor group
propofol+miR-802 inhibitor group
propofol+Vector group and propofol+pcDNA-PTCH1 group
cell viability
invasion and migration were detected. Western blotting was used to detect the protein expression level of PTCH1 and Gli1. RESULTS: Compared with the control group
the invasion and migration of HeLa cells in the propofol group decreased significantly
with statistically significant difference(P<0.05). Compared with the NC mimic group
the expression of miR-802 in HeLa cells in miR-802 mimic group increased significantly
and the cell viability
invasion and migration ability decreased
the differences were statistically significant(P<0.05). Compared with the control group
the expression of miR-802 in HeLa cells in the propofol+NC inhibitor group increased significantly; compared with the propofol+NC inhibitor group
the expression of miR-802 in HeLa cells in the propofol+miR-802 inhibitor group decreased significantly
the cell viability
invasion and migration ability increased
the differences were statistically significant(P<0.05). PTCH1 was identified as the target gene of miR-802. Compared with the NC inhibitor group
PTCH1 mRNA and protein levels in the miR-802 inhibitor group cells increased significantly
and Gli1 protein expression increased
the differences were statistically significant(P<0.05). Overexpression of PTCH1 reversed miR-802 and propofol-induced inhibition of HeLa cell viability
migration and invasion ability. CONCLUSIONS: Propofol inhibits the migration and invasion of cervical cancer cells by regulating the miR-802/PTCH1/SHH pathway.
Comparative Study on Different Administration Method of Propofol in Breast Cancer Surgery
Efficacy of Milnacipran Hydrochloride Tablets Combined with Shugan Jieyu Capsules in the Treatment of Anxiety and Depression After Cervical Cancer Chemotherapy and Its Effects on Lymphocyte Subsets,Sleep and Quality of Life
Clinical Observation of Self-Made Traditional Chinese medicine Decoction in the Treatment of Radiation Proctitis Induced by Radiotherapy of Cervical Cancer
Propofol for Sedation During Gastrointestinal Endoscopy: A Rapid Health Technology Assessment
Systematic Review of Effectiveness and Safety of Paclitaxel Combined with Carboplatin Synchronized with Radiotherapy and Chemotherapy in the Treatment of Cervical Cancer
Related Author
GAN Zuren
WU Jiaying
CAI Qinfeng
ZHOU Caishan
Munire·HUSAIYIN
ZOU Shaohong
SONG Shuyi
Adila·AJI
Related Institution
Dept.of Anesthesiology, Haikou Hospital of Traditional Chinese Medicine
Dept. of Clinical Psychology,People’s Hospital of Xinjiang Uygur Autonomous Region
Dept. of Clinical Psychology, People’s Hospital of Bayingolin Mongolian Autonomous Prefecture
Dept.of Pharmacy,Chongqing University Cancer Hospital
Cancer Treatment Center of Traditional Chinese Medicine,Chongqing University Cancer Hospital